The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Initial experience of patients treated in a real-world clinical setting with bevacizumab-awwb: The first FDA-approved biosimilar to bevacizumab.

Ran  Jin

Employment - Amgen

Stock and Other Ownership Interests  - Amgen

Neil A  Accortt

Employment - Amgen

Stock and Other Ownership Interests  - Amgen

Darcie  Sandschafer

Employment - Amgen

Stock and Other Ownership Interests  - Amgen

Expert Testimony - Amgen

Tatiana  Lawrence

Employment - Amgen

Stock and Other Ownership Interests  - Amgen

Arturo  Loaiza-Bonilla

Stock and Other Ownership Interests  - Massive Bio

Consulting or Advisory Role - Bayer; Boston Biomedical; BrightInsight; Cardinal Health; Massive Bio; Pfizer; PSI; QED Therapeutics; Taiho Pharmaceutical

Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Guardant Health; Natera

Research Funding - Ipsen (Inst)